Huningue, France, June 27, 2022
Firalis S.A. is pleased to announce the obtaining of the ISO 14001 certification for the development, production and sales of in vitro diagnostic tests, as well as for the storage and analysis of samples. ISO 14001 is an international standard that provides specific requirements for an effective Environmental Management System (EMS), enhancing performance to protect the environment and increasing the ability to meet supplier requirements.
As another major step took forward by Firalis, promoter of continuous improvement and committed to serve the biopharmaceutical industry with the highest quality standards that exist, ISO 14001 takes its place within the Quality Management System of Firalis, next to ISO 9001, ISO 13485, NFS S96-900 and others (www.firalis.com/quality) as the most respected environmental systems standard.
***
About FIRALIS S.A.
Firalis S.A. is a pioneering biotechnology company that offers CRO services and develops diagnostic products through discovery, development and regulatory qualification of innovative biomarkers for precision medicine, to improve prognosis of disease outcomes and therapeutic decisions. Firalis develops RUO (Research-Use-Only) and IVD (In-Vitro Diagnostic) kits, within the fields of cardiovascular diseases, neurodegenerative disorders (Alzheimer), inflammatory/autoimmune diseases and using cutting-edge technology platforms, with an exceptional team of experts and very high-quality industry standards.
Press contact : press{a}firalis.com